Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Methods of ensuring vaccine safety.

Ball R.

Expert Rev Vaccines. 2002 Aug;1(2):161-8. Review.

PMID:
12901555
2.

Immunization safety priority project at the World Health Organization.

Duclos P, Delo A, Aguado T, Bilous J, Birmingham M, Kieny MP, Milstien J, Wood D, Tarantola D.

Semin Pediatr Infect Dis. 2003 Jul;14(3):233-9.

PMID:
12913836
3.
4.

Weighing the risks and benefits of vaccination.

Glickman LT.

Adv Vet Med. 1999;41:701-13. Review.

PMID:
9890055
5.

Monitoring and assessing vaccine safety: a European perspective.

Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J.

Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Review.

PMID:
20370548
6.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
7.

Vaccinovigilance in Europe--need for timeliness, standardization and resources.

Lankinen KS, Pastila S, Kilpi T, Nohynek H, Mäkelä PH, Olin P.

Bull World Health Organ. 2004 Nov;82(11):828-35. Epub 2004 Dec 14.

8.

Vaccine safety: current systems and recent findings.

Wharton M.

Curr Opin Pediatr. 2010 Feb;22(1):88-93. doi: 10.1097/MOP.0b013e3283350425. Review.

PMID:
19952750
9.

What is vaccine advocacy? Proposal for a definition and action.

Balinska MA.

Vaccine. 2004 Mar 29;22(11-12):1335-42. Review.

PMID:
15063555
10.

Vaccination policies and programs: the federal government's role in making the system work.

Schwartz B, Orenstein WA.

Prim Care. 2001 Dec;28(4):697-711, v.

PMID:
11739026
11.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
12.

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.

Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat.

Expert Rev Vaccines. 2009 Jun;8(6):705-16. doi: 10.1586/erv.09.40. Review.

PMID:
19485752
13.

A global perspective on vaccine safety.

Duclos P.

Vaccine. 2004 May 7;22(15-16):2059-63. Review.

PMID:
15121323
14.

[Postmarketing surveillance of secondary effects of vaccines].

Duclos P.

Rev Epidemiol Sante Publique. 1994;42(5):425-33. French.

PMID:
7973002
15.

[Post-licensing surveillance of vaccines].

Launay O, Petitprez K, Lorrot M.

Therapie. 2005 May-Jun;60(3):209-14. Review. French.

PMID:
16128261
16.

Surveillance of adverse effects following vaccination and safety of immunization programs.

Waldman EA, Luhm KR, Monteiro SA, Freitas FR.

Rev Saude Publica. 2011 Feb;45(1):173-84. Review. English, Portuguese.

17.

Vaccine safety: risk communication--a global perspective.

Dittmann S.

Vaccine. 2001 Mar 21;19(17-19):2446-56. Review.

PMID:
11257376
18.

Postmarketing surveillance for dog and cat vaccines: new resources in changing times.

Moore GE, Frana TS, Guptill LF, Ward MP, Lewis HB, Glickman LT.

J Am Vet Med Assoc. 2005 Oct 1;227(7):1066-9. No abstract available.

PMID:
16220664
19.
20.

Field evaluation of vaccine safety.

Tozzi AE.

Vaccine. 2004 May 7;22(15-16):2091-5. Review.

PMID:
15121330

Supplemental Content

Support Center